Your browser doesn't support javascript.
loading
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study.
Battesti, Gilles; Garcia, Charline; Viguier, Manuelle; Marchal, Valentine; Castel, Marion; Joly, Pascal; Ledard, Anne-Pham; Konstantinou, Maria-Polina; Seta, Vannina; Cordel, Nadège; Duvert-Lehembre, Sophie; Tancrède-Bohin, Emmanuelle; Belmondo, Thibaut; Ingen-Housz-Oro, Saskia; d'Incan, Michel.
Afiliación
  • Battesti G; Department of Dermatology, AP-HP, Henri-Mondor Hospital, Créteil, France.
  • Garcia C; Department of Dermatology, CHU, Université Clermont-Auvergne, Clermont-Ferrand, France.
  • Viguier M; Department of Dermatology, Reims University Hospital, Reims, France; Bullous diseases French Study Group.
  • Marchal V; Department of Dermatology, Reims University Hospital, Reims, France.
  • Castel M; Bullous diseases French Study Group; Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France.
  • Joly P; Bullous diseases French Study Group; Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France.
  • Ledard AP; Bullous diseases French Study Group; Department of Dermatology, University of Bordeaux, Bordeaux, France.
  • Konstantinou MP; Bullous diseases French Study Group; Department of Dermatology, Dermatology Department, University Hospital of Toulouse, Toulouse, France.
  • Seta V; Bullous diseases French Study Group; Department of Dermatology, AP-HP, Cochin Hospital, Paris, France.
  • Cordel N; Bullous diseases French Study Group; Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Pointe-à-Pitre, France.
  • Duvert-Lehembre S; Bullous diseases French Study Group; Department of Dermatology, Dunkerque Hospital, Dunkerque, France; Department of dermatology, University of Lille, Lille, France.
  • Tancrède-Bohin E; Bullous diseases French Study Group; Department of dermatology, AP-HP, Saint- Louis Hospital, Paris, France.
  • Belmondo T; Bullous diseases French Study Group; Department of Immunology, AP-HP, Henri-Mondor Hospital, Créteil, France.
  • Ingen-Housz-Oro S; Department of Dermatology, AP-HP, Henri-Mondor Hospital, Créteil, France; Bullous diseases French Study Group; Univ Paris Est Créteil, EpiDermE, Créteil, France. Electronic address: saskia.oro@aphp.fr.
  • d'Incan M; Department of Dermatology, CHU, Université Clermont-Auvergne, Clermont-Ferrand, France; Bullous diseases French Study Group.
J Am Acad Dermatol ; 86(6): 1293-1300, 2022 06.
Article en En | MEDLINE | ID: mdl-35091001
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penfigoide Ampolloso Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penfigoide Ampolloso Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Francia